| Entry |
| ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Name | Oxacillin sodium (JAN/USP); Oxacillin sodium hydrate; Bactocill (TN) | ||||||||||
| Product | OXACILLIN (Baxter Healthcare Corporation) | ||||||||||
| Generic | OXACILLIN (Fresenius Kabi USA), OXACILLIN (Piramal Critical Care), OXACILLIN (Wockhardt USA LLC.), OXACILLIN (Wockhardt USA LLC.), OXACILLIN (AuroMedics Pharma LLC), OXACILLIN (AuroMedics Pharma LLC), OXACILLIN (Fresenius Kabi USA), OXACILLIN (Sagent Pharmaceuticals), OXACILLIN (Sagent Pharmaceuticals), OXACILLIN (Sagent Pharmaceuticals), OXACILLIN (Sagent Pharmaceuticals) | ||||||||||
| Formula | C19H18N3O5S. Na. H2O | ||||||||||
| Exact mass | 441.0971 | ||||||||||
| Mol weight | 441.4334 | ||||||||||
| Structure |  | ||||||||||
| Simcomp | |||||||||||
| Class | Antibacterial DG01710 beta-Lactam antibiotic DG01713 Penicillin skeleton group DG01480 Penicillin DG01779 beta-Lactamase resistant penicillin | ||||||||||
| Remark |
| ||||||||||
| Efficacy | Antibacterial, Cell wall biosynthesis inhibitor | ||||||||||
| Target | penicillin binding protein | ||||||||||
| Pathway |
| ||||||||||
| Interaction | |||||||||||
| Structure map |
| ||||||||||
| Brite | Anatomical Therapeutic Chemical (ATC) classification [BR:br08303] J ANTIINFECTIVES FOR SYSTEMIC USE J01 ANTIBACTERIALS FOR SYSTEMIC USE J01C BETA-LACTAM ANTIBACTERIALS, PENICILLINS J01CF Beta-lactamase resistant penicillins J01CF04 Oxacillin D00929 Oxacillin sodium (JAN/USP) <US> USP drug classification [BR:br08302] Antibacterials Beta-lactam, Penicillins Oxacillin D00929 Oxacillin sodium (JAN/USP) Drug groups [BR:br08330] Antibacterial DG01710 beta-Lactam antibiotic DG01713 Penicillin skeleton group DG01480 Penicillin DG00542 Oxacillin D00929 Oxacillin sodium DG01779 beta-Lactamase resistant penicillin DG00542 Oxacillin D00929 Oxacillin sodium Drug classes [BR:br08332] Antibacterial DG01480 Penicillin D00929 Oxacillin sodium Antimicrobials [BR:br08307] Antibacterials Cell wall biosynthesis inhibitor, beta-lactam beta-Lactamase resistant penicillin D00929 Oxacillin sodium (JAN/USP) <US> Drug groups [BR:br08330] Antibacterial DG01710 beta-Lactam antibiotic DG01713 Penicillin skeleton group DG01480 Penicillin DG00542 Oxacillin DG01779 beta-Lactamase resistant penicillin DG00542 Oxacillin Antimicrobials abbreviations [BR:br08327] Antibacterials Cell wall biosynthesis inhibitor, beta-lactam beta-Lactamase resistant penicillin DG00542 Oxacillin | ||||||||||
| Other DBs |
| ||||||||||
| KCF data | ATOM 30 1 C1y C 27.5667 -14.8899 2 C5x C 27.5667 -16.2792 3 N1y N 28.9560 -16.2792 4 C1y C 28.9560 -14.8899 5 C1y C 30.2759 -16.6960 6 C1z C 31.1096 -15.5845 7 S2x S 30.2759 -14.4731 8 C1a C 32.0821 -16.5571 9 C1a C 32.0821 -14.6120 10 C6a C 30.7622 -18.0854 11 O6a O 32.1515 -18.0854 #- 12 O6a O 29.9286 -19.1969 13 N1b N 26.3858 -14.1952 14 C5a C 25.2048 -14.8899 15 O5x O 26.3858 -16.9739 16 O5a O 25.2048 -16.2792 17 C8y C 23.9544 -14.1952 18 C8y C 23.9544 -12.8059 19 O2x O 22.6330 -12.3765 20 N5x N 21.8164 -13.5005 21 C8y C 22.6330 -14.6246 22 C1a C 25.0784 -11.9892 23 C8y C 22.6330 -16.0504 24 C8x C 21.3820 -16.7729 25 C8x C 21.3822 -18.1987 26 C8x C 22.6171 -18.9114 27 C8x C 23.8680 -18.1889 28 C8x C 23.8678 -16.7631 29 Z Na 33.7493 -18.1548 #+ 30 O0 O 34.0271 -19.9610 BOND 31 1 1 2 1 2 2 3 1 3 3 4 1 4 1 4 1 5 3 5 1 6 5 6 1 7 6 7 1 8 4 7 1 9 6 8 1 10 6 9 1 11 5 10 1 #Down 12 10 11 1 13 10 12 2 14 1 13 1 #Up 15 13 14 1 16 2 15 2 17 14 16 2 18 14 17 1 19 17 18 2 20 18 19 1 21 19 20 1 22 20 21 2 23 17 21 1 24 18 22 1 25 21 23 1 26 23 24 2 27 24 25 1 28 25 26 2 29 26 27 1 30 27 28 2 31 23 28 1 |